Imai H, Hirao F, Sakamoto T, Sekine K, Mizukura Y, Saito M et al
of course, ascertainment is difficult if the characteristic clinical dyad of hemolytic anemia and metabolic acidosis is not recognized and urine organic acid studies are not obtained
by Kara Dempster et al
A large sample size and long-term intervention are required for validation (41)
Why Standardizing Decision-Making Matters The real question isn't "What dose should we use?" It's, "How do we create a safe, compliant process?" That looks like: Written protocols Clear eligibility criteria Strong informed consent forms Set follow-up checks Adverse event reporting Staff training Standard workflows protect your patients, your providers, and your spa
Images were analyzed with ZEISS ZEN Blue and Fiji softwares